Assertio Holdings shares are trading higher after the company announced it entered into an Amended and Restated Agreement and Plan of Merger with Garda Therapeutics pursuant to which Garda has increased its offer to acquire all outstanding shares of Assertio to $21.80 per share in cash with no contingent value right.